Diabetes Breakthroughs Happen with 3D InSight™
jump to section
Meet the InSphero team at the American Diabetes Association 2018 meeting to learn how you can take full advantage of our 3D InSight™ Diabetes Discovery Platform.
Tailored Solutions for Research
- Discovery partnerships
- CRO services
- Assay-ready islet microtissues delivered to your lab
- Custom model development
Take advantage of our
high-throughput compatible scalable 3D Technology
Robust Islet Models Expert Assay Services
Uniform 3D InSight™ Microtissues
for reproducible results
Advanced Disease Modeling
Certified Applications
-
-
- β-cell function
- β-cell proliferation
- α-cell function
- Islet viability and apoptosis
-
Reliable Assessment of β-cell Function
Talk to our team at ADA to learn about our new partnership with ALPCO and our comprehensive β-cell function application suite that includes everything you need to quantify insulin secretion from 3D InSight™ Islet Microtissues.
-
- Use a robust and standardized primary islet model in high-throughput and longitudinal studies of β-cell function, regeneration and preservation
- Achieve robust and accurate quantification of insulin secretion from 3D InSight™ Islet Microtissues with the high sensitivity and broad dynamic range of ALPCO STELLUX® ELISAs
- Save time and ensure reliable, reproducible results by ordering media, buffers, and endpoint assays certified for use with 3D InSight™ Islet Microtissues
jump to section
Conference Details
-
-
- Conference Dates: June 22-26, 2018
-
- Orange County Convention Center, Orlando, FL USA
-
- Booth: 1567
-
jump to section
jump to section
In-Booth Poster Presentations
The following posters will be on display at InSphero Booth 1567, during exhibition hours, June 23 – 25.
Disease Modeling
Physiologically Relevant Disease Modeling with 3D InSight™ Human Islet Microtissues
Contributing Authors: Aparna Neelakandhan1, Adelinn Biernath1, Felix Forschler1, Joan Mir, Burcak Yesildag1; 1 InSphero AG, Schlieren, Switzerland
Contributing Authors: Aparna Neelakandhan1, Adelinn Biernath1, Felix Forschler1, Joan Mir, Burcak Yesildag1; 1 InSphero AG, Schlieren, Switzerland
Insulin Release Dynamics
Using Uniform Reaggregated Pancreatic Islets in a Microfluidic Perifusion System Enables Studying Insulin Release Dynamics at Single-Islet Level (in collaboration with ETH Zürich)
Contributing Authors: Burcak Yesildag1, Patrick M. Misun2, Felix Forschler2, Aparna Neelakandhan1, Adelinn Biernath1, Andreas Hierlemann2, Olivier Frey1; 1 InSphero AG, Schlieren, Switzerland; 2 ETH Zürich, Dept. of Biosystems Science and Engineering, Bio Engineering Laboratory, Basel, Switzerland
Contributing Authors: Burcak Yesildag1, Patrick M. Misun2, Felix Forschler2, Aparna Neelakandhan1, Adelinn Biernath1, Andreas Hierlemann2, Olivier Frey1; 1 InSphero AG, Schlieren, Switzerland; 2 ETH Zürich, Dept. of Biosystems Science and Engineering, Bio Engineering Laboratory, Basel, Switzerland
β-Cell Proliferation
A Novel Standardized In Vitro Model System for Assessment of Pancreatic β-Cell Proliferation
Contributing Authors: Burcak Yesildag1, Eva-Marie Andersson2, Aparna Neelakandhan1, Adelinn Biernath1, Laurent Knerr2, Henrik Gradén2, Carina Ämmälä2; 1InSphero AG, Schlieren, Switzerland, 2AstraZeneca, Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit – Mölndal, Sweden
Contributing Authors: Burcak Yesildag1, Eva-Marie Andersson2, Aparna Neelakandhan1, Adelinn Biernath1, Laurent Knerr2, Henrik Gradén2, Carina Ämmälä2; 1InSphero AG, Schlieren, Switzerland, 2AstraZeneca, Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit – Mölndal, Sweden
Pancreatic Islets on a Chip
Akura™ Flow: A Microfluidic Multi-Tissue Platform Engineered for 3D InSight™ Microtissues
Contributing Authors: Fabrizio Hürlimann¹, Christian Lohasz², Burçak Yesildag¹, David Fluri¹, Kasper Renggli², Andreas Hierlemann², Olivier Frey¹; ¹InSphero AG, Schlieren, Switzerland; ²ETH Zürich, Department of Biosystems Science and Engineering, Basel, Switzerland
Contributing Authors: Fabrizio Hürlimann¹, Christian Lohasz², Burçak Yesildag¹, David Fluri¹, Kasper Renggli², Andreas Hierlemann², Olivier Frey¹; ¹InSphero AG, Schlieren, Switzerland; ²ETH Zürich, Department of Biosystems Science and Engineering, Basel, Switzerland